Hepatology Table of Contents 

|

As an AASLD Member, you can also visit the Hepatology EarlyView, which gives members direct access to the journal articles ahead of print publication.

AASLD Position Statement

Position statement: Nonanesthesiologist administration of propofol for GI endoscopy

Comments from the Editors

Editorials

Innate response to hepatitis B virus infection: Observations challenging the concept of a stealth virus

Fetal obesity syndrome: Maternal nutrition as a cause of nonalcoholic steatohepatitis

Alanine aminotransferase: Is it healthy to be normal?

Viral Hepatitis

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients

Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein

Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial

Public health impact of antiviral therapy for hepatitis C in the United States

The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production

High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy

Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection

Steatohepatitis/Metabolic Liver Disease

Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin

Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression

Activation of the complement system in human nonalcoholic fatty liver disease

Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial

The plasma lipidomic signature of nonalcoholic steatohepatitis

Hepatobiliary Malignancies

Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma

Ikappa B kinase/nuclear factor-B activation controls the development of liver metastasis by way of interleukin-6 expression

Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2

Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism

Autoimmune, Cholestatic and Biliary Disease

Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: A population-based study

B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor- receptor II dominant negative mice

Priming of CD4+ T cells by liver sinusoidal endothelial cells induces CD25low forkhead box protein 3- regulatory T cells suppressing autoimmune

Liver Failure/Cirrhosis/Portal Hypertension

Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure

Role of 3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis

Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis

Liver Injury/Regeneration

Cyclin-dependent kinase 1 plays a critical role in DNA replication control during rat liver regeneration

Variability in the upper limit of normal for serum alanine aminotransferase levels: A statewide study

In vivo phosphoenolpyruvate carboxykinase promoter mapping identifies disrupted hormonal synergism as a target of inflammation during sepsis in mice

Liver Biology/Pathobiology

BH3-only protein bid participates in the Bcl-2 network in healthy liver cells

Mechanistic insights into immunomodulation by hepatic stellate cells in mice: A critical role of interferon- signaling

Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload

Rapid Communication

Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

Reviews

Epithelial-to-mesenchymal transitions in the liver

Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy

Severe sepsis in cirrhosis

Hepatology Elsewhere

Results of the IDEAL trial: Mirror, mirror on the wall Which's the fairest peg-interferon of them all?

Cooperation of innate and adaptive immunity in the pathogenesis of biliary atresia: There's a killer on the run

Shortcut to death

Image of the Month

Jaundice after allogeneic hematopoietic stem cell transplantation

Correspondence

The reprogramming factors of human somatic cells are novel targets for human hepatocellular carcinoma therapy

Differentiation therapy with transcription factors might present as an ideal strategy for the treatment of cancer

What is the relationship among microRNA-181, epithelial cell-adhesion molecule (EpCAM) and -catenin in hepatic cancer stem cells

Reply

Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease

Reply

A novel method in order to evaluate the efficacies and the safeties of new drugs for hepatocellular carcinoma with loss of transforming growth factor- signaling

Reply

Is endoscopic band ligation necessary for primary prophylaxis of esophageal varices without high bleeding risks?

Reply

Radiofrequency ablation in patients with hepatocellular carcinoma

Reply

Metformin, hepatitis C, and insulin resistance: Sufficient evidence?

Reply

Abstracts

This is the full text of the late-breaking abstracts (it was not included in the printed books). We apologize for any inconvenience.